Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...

Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...

Rhythm Pharmaceuticals develops medicines for rare disorders that cause weight gain. The company's only approved product is ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

You have been exercising, eating home-cooked meals, and have managed to cut out fried food and desserts from your diet for ...

Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...

India is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the ...